The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
A structural basis for drug-induced long QT syndrome
Open accessAbstract
Mutations in the HERG K + channel gene cause inherited long QT syndrome (LQT), a disorder of cardiac repolarization that predisposes affected individuals to lethal arrhythmias [Curran, M. E., Splawski, I., Timothy, K. W., Vincent, G. M., Green, E. D. & Keating, M. T. (1995) Cell 80, 795–804]. Acquired LQT is far more common and is most often caused by block of cardiac HERG K + channels by commonly used medications [Roden, D. M., Lazzara, R., Rosen, M., Schwartz, P. J., Towbin, J. & Vincent, G. M. (1996) Circulation 94, 1996–2012]. It is unclear why so many structurally diverse compounds block HERG channels, but this undesirable side effect now is recognized as a major hurdle in the development of new and safe drugs. Here we use alanine-scanning mutagenesis to determine the structural basis for high-affinity drug block of HERG channels by MK-499, a methanesulfonanilide antiarrhythmic drug. The binding site, corroborated with homology modeling, is comprised of amino acids located on the S6 transmembrane domain (G648, Y652, and F656) and pore helix (T623 and V625) of the HERG channel subunit that face the cavity of the channel. Other compounds that are structurally unrelated to MK-499, but cause LQT, also were studied. The antihistamine terfenadine and a gastrointestinal prokinetic drug, cisapride, interact with Y652 and F656, but not with V625. The aromatic residues of the S6 domain that interact with these drugs (Y652 and F656) are unique to eag/erg K + channels. Other voltage-gated K + (Kv) channels have Ile and Val (Ile) in the equivalent positions. These findings suggest a possible structural explanation for how so many commonly used medications block HERG but not other Kv channels and should facilitate the rational design of drugs devoid of HERG channel binding activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Structure of the Potassium Channel: Molecular Basis of K + Conduction and Selectivity
Doyle, D. A., Cabral, J. M., Pfuetzner, R. A., Kuo, A., Gulbis, J. M., Cohen, S. L., Chait, B. T., & MacKinnon, R. (1998) · Science · doi:10.1126/science.280.5360.69 · Cited by 6,807
Sanguinetti, M. C., Jiang, C., Curran, M. E., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90340-2 · Cited by 2,423
Self-citationCardiac Electrophysiology: From Cell to Bedside
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-12-1069_5 · Cited by 2,385
A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome
Curran, M. E., Splawski, I., Timothy, K. W., Vincen, G. M., Green, E. D., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90358-5 · Cited by 2,259
MiRP1 Forms IKr Potassium Channels with HERG and Is Associated with Cardiac Arrhythmia
Abbott, G. W., Sesti, F., Splawski, I., Buck, M. E., Lehmann, M. H., Timothy, K. W., Keating, M. T., & Goldstein, S. A. N. (1999) · Cell · doi:10.1016/s0092-8674(00)80728-x · Cited by 1,354
HERG, a Human Inward Rectifier in the Voltage-Gated Potassium Channel Family
Trudeau, M. C., Warmke, J. W., Ganetzky, B., & Robertson, G. A. (1995) · Science · doi:10.1126/science.7604285 · Cited by 1,239
A family of potassium channel genes related to eag in Drosophila and mammals.
Warmke, J. W., & Ganetzky, B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3438 · Cited by 982
The inward rectification mechanism of the HERG cardiac potassium channel
Smith, P. L., Baukrowitz, T., & Yellen, G. (1996) · Nature · doi:10.1038/379833a0 · Cited by 754
Multiple Mechanisms in the Long-QT Syndrome: Current Knowledge, Gaps, and Future Directions
Roden, D. M., Lazzara, R., Rosen, M., Schwartz, P. J., Towbin, J., & Vincent, G. M. (1996) · Circulation · doi:10.1161/01.cir.94.8.1996 · Cited by 628
Ragsdale, D. S., McPhee, J. C., Scheuer, T., & Catterall, W. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9270 · Cited by 498
Cited by
hERG potassium channels and cardiac arrhythmia
Sanguinetti, M. C., & Tristani-Firouzi, M. (2006) · Nature · doi:10.1038/nature04710 · Cited by 1,572
Self-citationREDFERN, W., CARLSSON, L., DAVIS, A., LYNCH, W., MACKENZIE, I., PALETHORPE, S., SIEGL, P., STRANG, I., SULLIVAN, A., & WALLIS, R. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00846-5 · Cited by 1,532
The open pore conformation of potassium channels
Jiang, Y., Lee, A., Chen, J., Cadene, M., Chait, B. T., & MacKinnon, R. (2002) · Nature · doi:10.1038/417523a · Cited by 1,197
Self-citationBasic Mechanisms of Cardiac Impulse Propagation and Associated Arrhythmias
KLÉBER, A. G., & RUDY, Y. (2004) · Physiological Reviews · doi:10.1152/physrev.00025.2003 · Cited by 1,083
Molecular and Cellular Mechanisms of Cardiac Arrhythmias
Keating, M. T., & Sanguinetti, M. C. (2001) · Cell · doi:10.1016/s0092-8674(01)00243-4 · Cited by 1,001
Self-citationIncardona, J. P., Collier, T. K., & Scholz, N. L. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2003.11.026 · Cited by 833
hERG K+Channels: Structure, Function, and Clinical Significance
Vandenberg, J. I., Perry, M. D., Perrin, M. J., Mann, S. A., Ke, Y., & Hill, A. P. (2012) · Physiological Reviews · doi:10.1152/physrev.00036.2011 · Cited by 696
Potassium channel receptor site for the inactivation gate and quaternary amine inhibitors
Zhou, M., Morais-Cabral, J. H., Mann, S., & MacKinnon, R. (2001) · Nature · doi:10.1038/35079500 · Cited by 560
Farid, R., Day, T., Friesner, R. A., & Pearlstein, R. A. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.12.032 · Cited by 502
Cryo-EM Structure of the Open Human Ether-à-go-go -Related K + Channel hERG
Wang, W., & MacKinnon, R. (2017) · Cell · doi:10.1016/j.cell.2017.03.048 · Cited by 500
The impact of drug-induced QT interval prolongation on drug discovery and development
Fermini, B., & Fossa, A. A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1108 · Cited by 492
Pharmacology of cardiac potassium channels
Tamargo, J. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.12.026 · Cited by 466
Personalized medicine: revolutionizing drug discovery and patient care
Ginsburg, G. (2001) · Trends in Biotechnology · doi:10.1016/s0167-7799(01)01814-5 · Cited by 456
H1‐antihistamines: inverse agonism, anti‐inflammatory actions and cardiac effects
Leurs, R., Church, M. K., & Taglialatela, M. (2002) · Clinical & Experimental Allergy · doi:10.1046/j.0954-7894.2002.01314.x · Cited by 450
Kannankeril, P., Roden, D. M., & Darbar, D. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.003723 · Cited by 440
Medicinal Chemistry of hERG Optimizations: Highlights and Hang-Ups
Jamieson, C., Moir, E. M., Rankovic, Z., & Wishart, G. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060379l · Cited by 423
Moss, A. J., Zareba, W., Kaufman, E. S., Gartman, E., Peterson, D. R., Benhorin, J., Towbin, J. A., Keating, M. T., Priori, S. G., Schwartz, P. J., et al. (2002) · Circulation · doi:10.1161/hc0702.105124 · Cited by 397
Cavalli, A., Poluzzi, E., De Ponti, F., & Recanatini, M. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0208875 · Cited by 382
Gupta, A., Lawrence, A. T., Krishnan, K., Kavinsky, C. J., & Trohman, R. G. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.01.040 · Cited by 362
Drug‐Induced Torsades de Pointes and Implications for Drug Development
FENICHEL, R. R., MALIK, M., ANTZELEVITCH, C., SANGUINETTI, M., RODEN, D. M., PRIORI, S. G., RUSKIN, J. N., LIPICKY, R. J., CANTILENA, L. R., & Independent Academic Task Force (2004) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2004.03534.x · Cited by 346
Self-citationhERG toxicity assessment: Useful guidelines for drug design
Garrido, A., Lepailleur, A., Mignani, S. M., Dallemagne, P., & Rochais, C. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112290 · Cited by 344
Marbán, E. (2002) · Nature · doi:10.1038/415213a · Cited by 328
Long QT syndrome: reduced repolarization reserve and the genetic link
RODEN, D. M. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01589.x · Cited by 322
Utility of homology models in the drug discovery process
Hillisch, A., Pineda, L. F., & Hilgenfeld, R. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03196-4 · Cited by 310
Ponti, F. D., Poluzzi, E., Cavalli, A., Recanatini, M., & Montanaro, N. (2002) · Drug Safety · doi:10.2165/00002018-200225040-00004 · Cited by 309
Roden, D. M., Balser, J. R., George Jr, A. L., & Anderson, M. E. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.083101.145105 · Cited by 305
Toward in silico structure-based ADMET prediction in drug discovery
Moroy, G., Martiny, V. Y., Vayer, P., Villoutreix, B. O., & Miteva, M. A. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2011.10.023 · Cited by 302
Navarrete, E. G., Liang, P., Lan, F., Sanchez-Freire, V., Simmons, C., Gong, T., Sharma, A., Burridge, P. W., Patlolla, B., Lee, A. S., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.000570 · Cited by 302
Predicting drug–hERG channel interactions that cause acquired long QT syndrome
Sanguinetti, M. C., & Mitcheson, J. S. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.01.003 · Cited by 300
Self-citationThe hERG potassium channel and hERG screening for drug-induced torsades de pointes
Hancox, J. C., McPate, M. J., El Harchi, A., & Zhang, Y. H. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.05.009 · Cited by 299
Long QT syndrome: from channels to cardiac arrhythmias
Moss, A. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25537 · Cited by 296
Recanatini, M., Poluzzi, E., Masetti, M., Cavalli, A., & De Ponti, F. (2005) · Medicinal Research Reviews · doi:10.1002/med.20019 · Cited by 285
HERG K+ channels: friend and foe
Vandenberg, J. I., Walker, B. D., & Campbell, T. J. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01662-x · Cited by 284
Predictive in silico modeling for hERG channel blockers
Aronov, A. M. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03278-7 · Cited by 267
Physicochemical Features of the hERG Channel Drug Binding Site
Fernandez, D., Ghanta, A., Kauffman, G. W., & Sanguinetti, M. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310683200 · Cited by 266
Self-citationInfluence of Opioid Agonists on Cardiac Human Ether-a-go-go-related Gene K+ Currents
Katchman, A. N., McGroary, K. A., Kilborn, M. J., Kornick, C. A., Manfredi, P. L., Woosley, R. L., & Ebert, S. N. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.038240 · Cited by 264
Ekins, S., Crumb, W. J., Sarazan, R. D., Wikel, J. H., & Wrighton, S. A. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.2.427 · Cited by 260
Langheinrich, U., Vacun, G., & Wagner, T. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2003.07.012 · Cited by 259
Pred‐hERG: A Novel web‐Accessible Computational Tool for Predicting Cardiac Toxicity
Braga, R. C., Alves, V. M., Silva, M. F. B., Muratov, E., Fourches, D., Lião, L. M., Tropsha, A., & Andrade, C. H. (2015) · Molecular Informatics · doi:10.1002/minf.201500040 · Cited by 256
Genetics of acquired long QT syndrome
Roden, D. M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25539 · Cited by 256
Human engineered heart tissue as a model system for drug testing
Eder, A., Vollert, I., Hansen, A., & Eschenhagen, T. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.05.010 · Cited by 190
Alarms about structural alerts
Alves, V. M., Muratov, E. N., Capuzzi, S. J., Politi, R., Low, Y., Braga, R. C., Zakharov, A. V., Sedykh, A., Mokshyna, E., Farag, S., et al. (2016) · Green Chemistry · doi:10.1039/c6gc01492e · Cited by 133
Ranolazine: Ion‐channel‐blocking actions and in vivo electrophysiological effects
Schram, G., Zhang, L., Derakhchan, K., Ehrlich, J. R., Belardinelli, L., & Nattel, S. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705879 · Cited by 101
Rodriguez-Menchaca, A., Ferrer-Villada, T., Lara, J., Fernandez, D., Navarro-Polanco, R. A., & Sanchez-Chapula, J. A. (2006) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000191564.52242.00 · Cited by 39
Wang, Z., Rumrill, S., Kang, D., Guma, S. D., Feng, D., De Clercq, E., Pannecouque, C., Chen, C. H., Arnold, E., Ruiz, F. X., et al. (2025) · Science Advances · doi:10.1126/sciadv.adt8916 · Cited by 7
Wess (2001) · doi:10.1002/1521-3773(20010917)40:18<3341::aid-anie3341>3.0.co;2-d
Metadata
- Authors
- Mitcheson, J. S., Chen, J., Lin, M., Culberson, C., & Sanguinetti, M. C.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2000-09-26
- Volume
- 97
- Issue
- 22
- Pages
- 12329-12333
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2107763854
- Cited by
- 944
- References
- 28
- FWCI
- 32.67
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.